Want to see TSE:BBM full AI Analyst Report?
BBM Stock Chart & Stats
C$0.02
<C$0.01(33.33%)
At close: 4:00 PM EDT
C$0.02
<C$0.01(33.33%)
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.02
Previous CloseN/A
Volume35.27K
Average Volume (3M)38.76K
Market Cap
C$7.43M
Enterprise ValueC$4.94
Total Cash (Recent Filing)C$14.77K
Total Debt (Recent Filing)C$8.28K
Price to Earnings (P/E)―
Beta-2.20
Next Earnings
Nov 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding495,090,100
10 Day Avg. Volume5,650
30 Day Avg. Volume38,759
Financial Highlights & Ratios
PEG Ratio-0.14
Price to Book (P/B)14.73
Price to Sales (P/S)15.15
P/FCF Ratio-3.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Lower LeverageSubstantially lower leverage reduces the company’s dependence on debt financing and limits fixed financial obligations. Although equity erosion remains a concern, the current debt burden is modest relative to prior years, providing some balance-sheet support over the next several quarters.
Gross Margin ImprovementThe sharp improvement in gross margin indicates better economics on the revenue the company does generate. If maintained, this progress could support future operating leverage and improve the path toward breakeven, even though current operating costs still overwhelm gross profit.
Reduced Cash BurnA lower cash-burn rate represents operational progress and could extend the period before additional funding is required. However, the improvement is not yet sufficient to create self-funding operations, so its lasting value depends on continued reductions in cash use.
Bears Say
Declining RevenueFalling revenue signals that the current business is not consistently expanding its commercial base. Continued top-line weakness would make it harder to absorb fixed operating costs, sustain investment, and convert margin improvement into durable profitability over the next several quarters.
Severe Operating LossesLosses of this magnitude show that operating expenses remain far above the company’s revenue base, despite improved gross margin. The business has not demonstrated a credible operating-breakeven path, making profitability highly dependent on substantial revenue growth or further cost reductions.
Equity ErosionThe steep contraction in equity reflects the cumulative effect of ongoing losses and leaves a much thinner balance-sheet cushion. This weakens financial resilience and reduces flexibility to fund operations internally while the company continues reporting deeply negative returns.
Blueberries Medical News
BBM FAQ
What was Blueberries Medical Corp’s price range in the past 12 months?
Blueberries Medical Corp lowest stock price was C$0.01 and its highest was C$0.02 in the past 12 months.
What is Blueberries Medical Corp’s market cap?
Blueberries Medical Corp’s market cap is C$7.43M.
When is Blueberries Medical Corp’s upcoming earnings report date?
Blueberries Medical Corp’s upcoming earnings report date is Nov 30, 2026 which is in 76 days.
How were Blueberries Medical Corp’s earnings last quarter?
Blueberries Medical Corp released its earnings results on Aug 31, 2026. The company reported C$0 earnings per share for the quarter.
Is Blueberries Medical Corp overvalued?
According to Wall Street analysts Blueberries Medical Corp’s price is currently Overvalued.
Does Blueberries Medical Corp pay dividends?
Blueberries Medical Corp does not currently pay dividends.
What is Blueberries Medical Corp’s EPS estimate?
Blueberries Medical Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Blueberries Medical Corp have?
Blueberries Medical Corp has 495,090,100 shares outstanding.
What happened to Blueberries Medical Corp’s price movement after its last earnings report?
Blueberries Medical Corp reported an EPS of C$0 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Blueberries Medical Corp?
Currently, no hedge funds are holding shares in TSE:BBM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Blueberries Medical Corp
Headquartered in Bogotá, Colombia, Blueberries Medical Corp. operates within the medicinal cannabis industry. The company's activities encompass the entire process, from cultivating and developing to producing and supplying medical-grade cannabis and its associated products across Colombia. Their offerings notably include medicinal cannabis oil extracts and other complementary items.